OPIANT PHARMACEUTICALS, INC.

SANTA MONICA, CALIFORNIA 904012213

$2.12M
Total Contract Value
2 awards
First Award
Jan 18, 2022
Last Award
Jan 2, 2024
Business Size
small
CAGE Code
73QL8

Top Industries (NAICS)

NAICS CodeObligationsAwards
541715$2.12M2

Contract Awards

2 awards found

75A50118D00029
Department of Health and Human Services
$-95,516.4
Jan 2, 2024

DE-OBLIGATE $95,516.40 FROM CLIN 0003 OPTION 2 FOR CLOSEOUT.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
75A50118D00029
Department of Health and Human Services
$2.21M
Jan 18, 2022

EXTEND THE PERIOD OF PERFORMANCE FOR OPTION 1/CLIN 0002 AND INCREASE FUNDING, REVISE THE CONTRACTING OFFICER, AND ADD HHSAR CLAUSE 352.232-71.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2022

Business Details

UEI
KM23KYBML5N8
CAGE Code
73QL8
Address
201 SANTA MONICA BLVD STE 500
SANTA MONICA, CA 904012213
Congressional District
CA-36

Parent Company

OPIANT PHARMACEUTICALS, INC.

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov